Wednesday, September 23, 2020

3 former pharmacy execs indicted in alleged $50 million healthcare fraud scheme


3 former pharmacy execs indicted in alleged $50 million healthcare fraud scheme

Becker's Hospital Review

Three former executives of a Louisiana compounding pharmacy were indicted in an alleged $50 million scheme to defraud New Jersey and military health benefits programs. The three executives worked for Central Rexall Drugs, a compounding pharmacy in Hammond, La. Christopher Johnston was general counsel, Trent Brock was COO and Christopher Casseri was vice president of sales. According to U.S. Attorney Craig Carpenito of the District of New Jersey, the three men learned that some insurance plans — including plans for New Jersey state and local government and education employees and the military insurer Tricare — would reimburse thousands of dollars for one-month supplies of some compounded drugs.

READ MORE

No comments:

Post a Comment